PharmaCom BioVet, Inc. (PHMB)
Treats cancer in pets through bone marrow transplants and specialized therapies.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
PHMB trades at its 52-week high, sitting above both its 50- and 200-day moving averages. Analyst coverage appears thin or unavailable for this micro-cap stock. The data reflects a stock at elevated levels within its recent range, though investors should note the extremely low share price and limited visibility typical of stocks at this market cap.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$1.1M
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—